FDA Restrictions On Rx Acetaminophen Show How Practical Concerns Influence Safety Actions
This article was originally published in The Pink Sheet Daily
Executive Summary
Because the agency can move faster on Rx products than OTCs, non-prescription products will have higher acetaminophen levels than Rx drugs, at least for the time being.
You may also be interested in...
FDA’s Rx Acetaminophen Safety Program Ramps Up Enforcement
Some manufacturers have not met a deadline FDA set three years ago to limit the amount of acetaminophen in prescription combination products to no more than 325 mg.
Actavis’ MoxDuo: Can A Generic Firm Drive Growth With A Low-Dose Product?
Actavis aims to replace its Kadian pain franchise through a deal with QRxPharma for a fixed-dose combination of morphine and oxycodone.
Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
A white paper by the National Council for Prescription Drug Programs calls on industry to harmonize Rx labeling with existing labeling for OTC medicines.